MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/ijgc-2022-003347

Медицинская библиотека · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2022

Trans-inguinal pelvic lymphadenectomy in vulvar cancer patients: TRIPLE pilot study.

Garganese Giorgia, Fragomeni Simona Maria, Della Corte Luigi, Conte Carmine, Marinucci Benito, Tagliaferri Luca, Gentileschi Stefano, Corrado Giacomo, Vizzielli Giuseppe, Scambia Giovanni

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

The goal of this study was to assess the feasibility and safety of a retrograde extraperitoneal trans-inguinal novel approach to pelvic lymphadenectomy in vulvar cancer patients. The secondary objectives were to assess complications (early and late) and oncological outcomes.

METHODS

In this pilot study, all patients referred to our institution from November 2019 to May 2021 were evaluated. The inclusion criteria were patients diagnosed with primary/recurrent vulvar cancer and who were candidates for concomitant groin and pelvic lymph node dissection. A consecutive sampling was planned during the study period. After conventional inguino-femoral lymph nodal dissection, ipsilateral extraperitoneal trans-inguinal pelvic lymphadenectomy (TRIPLE) was performed through a groin incision. Clinical data, type of treatment, perioperative complications, and follow-up were evaluated.

RESULTS

13 patients (8 primary, 5 recurrent vulvar cancer) underwent 16 TRIPLE procedures (10 unilateral, 3 bilateral). The median age was 69 years (range 58-93 years); 8 patients had comorbidities (61.5%). Up front locoregional radiotherapy was previously performed in two cases (15.4%). The pathology report showed metastatic lymph nodes in 20 (87%) groins and 11 (68.8%) pelvic sites; the mean number of removed and metastatic pelvic lymph nodes was 12.1 (range 5-33) and 2.9 (range 0-18), respectively. No intra-operative site-specific complications occurred. One (5.9%) post-operative site-specific complication was reported (pelvic abscess, grade 2), which was treated with antibiotics. One patient died due to concomitant pneumonia. No unilateral pelvic lymph node recurrence occurred during follow-up (median 13 months, range 2-43 months); 3 patients (23.1%) had distant site recurrence (median disease-free survival 9 months).

CONCLUSIONS

TRIPLE seems to be a feasible and safe technique, providing adequate lymph node dissection. Despite being a high-risk and fragile population, morbidity was similar to previously reported data for conventional mini-invasive approaches. Prospective larger comparative series are necessary.

Для цитирования: Garganese Giorgia, Fragomeni Simona Maria, Della Corte Luigi, Conte Carmine, Marinucci Benito, Tagliaferri Luca, Gentileschi Stefano, Corrado Giacomo, Vizzielli Giuseppe, Scambia Giovanni. Trans-inguinal pelvic lymphadenectomy in vulvar cancer patients: TRIPLE pilot study.. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2022. DOI: 10.1136/ijgc-2022-003347.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.